Abstract
Objectives: One of the most important problems that will affect the quality of life and even the progression of patients with chronic kidney disease (CKD) is the development of anemia. Intravenous iron replacement therapy is more frequently preferred in patients with CKD because of the problems of tolerance of the drugs and the often unsatisfactory treatment response. Intravenous iron replacement can cause hypophosphatemia and can affect mineral and bone disorders seen in CKD patients. Our study was planned to examine the effects of intravenous iron preparations on calcium, phosphorus, and parathormone levels, which are frequently used in treatment.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
